| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20K | -95.3% |
| R&D Expense | $82.2M | +25.0% |
| SG&A Expense | $21.0M | +15.6% |
| Operating Income | -$103.2M | -7.6% |
| Pre-tax Income | -$95.1M | -7.5% |
| Net Income | -$95.1M | -7.5% |
| EPS (Basic) | -$1.34 | +19.3% |
| EPS (Diluted) | -$1.34 | +19.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.9M | -72.7% |
| Short-term Investments | $95.0M | +51.5% |
| Accounts Receivable | $544K | -51.0% |
| Current Assets | $137.3M | -34.5% |
| Total Assets | $139.3M | -33.9% |
| Current Liabilities | $10.5M | -13.8% |
| Total Liabilities | $15.8M | -4.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.8M | -5.3% |
| Capital Expenditures | $47K | +0.0% |
| Investing Cash Flow | -$28.4M | -306.7% |
| Financing Cash Flow | $10.0M | -88.3% |
| Free Cash Flow | -$79.9M | -5.3% |
| Stockholders' Equity |
| $123.5M |
| -36.4% |